Skip to main content
. 2018 May 26;42(4):549–561. doi: 10.1016/j.jgr.2018.05.002

Table 3.

Clinical data on red ginseng as a health functional food

Samples Design Participants Daily intake/intake duration Results References
Red ginseng powder Random (no placebo) 36 stomach cancer patients and 36 colorectal cancer patients 4.5 g/6 months
  • -

    The number of suppressor/cytotoxic cells, helper/inducer cells, NK cells, activated T cells, and B cells in the red ginseng group increased significantly in the red ginseng group

[36]
Red ginseng extract Random (no placebo) 25 healthy individuals and 50 stomach cancer patients 3 g/3 months
  • -

    IL-2 and decrease rate of IL-10 were higher in the red ginseng group than in the control group

[37]
Red ginseng extract Random (no placebo) 47 colorectal cancer patients 3 g/3 months
  • -

    IL-2, IL-8, and IL-10 activity was regulated in the red ginseng group than in the control group

[38]
Red ginseng powder Case study 12,295 common cold patients No dose
  • -

    The ratio of those who caught the common cold was significantly lower in the red ginseng group.

[39]
Red ginseng powder Random, double-blind, placebo-controlled study1) 24 male college students 2.5-4 g/3 weeks
  • -

    The red ginseng group significantly recovered CK and GOT activity and the range of motion of related joints

[43]
Red ginseng extract Placebo-controlled study 24 students majoring in physical education 3 g/8 weeks
  • -

    Red ginseng intake did not affect the ability to perform aerobic or anaerobic exercise.

  • -

    O2 max, %VO2/VO2 max, and plasma BCAA and blood lactic acid tended to decrease.

[44]
Red ginseng extract Random, double-blind, placebo-controlled study 18 healthy men 60 g/11 days
  • -

    The red ginseng group decreased in blood CK, IL-6, insulin, and blood glucose.

[45]
Red ginseng extract Random, double-blind, control study 87 healthy men and women aged 20-59 years 1.5 g, 3 g/8 weeks
  • -

    Suppression of platelet aggregation due to ADP and collagen inducement

  • -

    No significant differences in blood coagulation (APTT and PT) and lipids

[52]
Red ginseng products Case study 10 red ginseng product takers and 7 non-red ginseng product takers 1.6 g/4-5 years
  • -

    Collagen-induced platelet aggregation was suppressed in the red ginseng group—APTT was significantly extended in the red ginseng group.

[53]
Red ginseng extract Random, double-blind, control study 15 healthy men 200 mg/8 weeks
  • -

    The red ginseng group exhibited significant improvements in or on the 3-back task and the Corsi block-tapping test.

  • -

    There were significant improvements in social relationships in the WHO Quality of Life-BREF as well.

[62]
Red ginseng powder Random, placebo-controlled, open-label (open study) 31 Alzheimer's disease patients aged 50 years or above taking medication 4.5 g or 9.0 g/12 weeks
  • -

    The high-dose red ginseng group improved significantly on both the ADAS and the CDR.

[64]
Red ginseng powder Double-blind, random, placebo-controlled 15 healthy, smoking male students aged 19-31 years (smoked 20 cigarettes/day or above in the past 2 years) 1.8 g/4 weeks
  • -

    Time-dependent decrease in the 8-OHdG concentration in smokers who had taken red ginseng was clearly confirmed.

  • -

    Red ginseng intake significantly decreased the carbonyl content (protein oxidation) of peripheral hemoglobin in comparison with the baseline.

[74]
Red ginseng extract Random, placebo-controlled 40 male college students 2.7 g/3 months
  • -

    Red ginseng group exhibited significant effects in SOD, GPX, and MDA

[47]
Red ginseng powder Random, double-blind, placebo-controlled 57 healthy drinking and smoking adults aged 20-65 years 3 g or 6 g/8 weeks
  • -

    DNA damages, SOD, GPX, CAT, blood oxidized LDL, and urine 8-epi PGF2α improved in red ginseng groups

[75]
Red ginseng powder Random, double-blind, placebo-controlled 82 menopausal women aged 45-60 years 3 g/12 weeks
  • -

    SOD activity increased significantly in the red ginseng group.

  • -

    No effect on GPX, 8-OHdG, IL-6, AST, ALT, and γ-GTP

[76]
Red ginseng powder Random, double-blind, placebo-controlled 63 menopausal women aged 45-60 years 3 g/12 weeks
  • -

    The red ginseng group exhibited significant improvements in Kupperman and menopause rating index and total and LDL-cholesterol.

  • -

    No difference in the estradiol (E2) concentration

[77]
Red ginseng extract Random, double-blind, placebo-controlled 26 menopausal women with hot flashes 0.9 g/8 weeks
  • -

    The frequency of the occurrence of hot flash symptoms decreased significantly in the red ginseng group.

[78]
Red ginseng powder Comparison before and after intake 83 menopausal women 6 g/8 weeks
  • -

    Follicle-stimulating hormones decreased and E2, red blood cell deformability, and ATP increased.

[79]
Red ginseng powder - 17 menopausal women 6 g/3 months
  • -

    Vital energy deficiency (KI-deficiency), blood stasis (oketsu), and simplified menopausal index decreased to the levels of the healthy (i.e., without climacteric syndromes) menopausal women's group after red ginseng intake.

  • -

    t-PAI-1 decreased significantly after red ginseng intake.

[80]
Red ginseng powder - Women with estrogen levels of 10 pg/ml or below 6 g/30 days
  • -

    The anxiety (A)-state in the Cornel Medical Index and the State-Trait Anxiety Inventory was found to recover to levels of the menopausal women's group without climacteric syndromes and the cortisol/DHEA-S ratio decreased significantly after red ginseng intake.

[81]

ADP, adenosine diphosphate; ADAS, Alzheimer's Disease Assessment Scale; ALT, alanine aminotransferase; APTT, activated partial thromboplastin time; AST, aspartate aminotransferase; BCAA, branched-chain amino acid; CAT, catalase; CDR, clinical dementia rating; CK, creatine kinase; DHEA, dehydroepiandrosterone; GOT, glutamic oxaloacetic transaminase; GPX, glutathione peroxidase; γ-GTP, γ-glutamyl transpeptidase; IL, interleukin; LDL, low-density lipoprotein; MDA, malondialdehyde; NK, natural killer; PT, prothrombin time; SOD, superoxide dismutase.

1)

A randomized, double-blind, and placebo-controlled trial.